Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000121704 | SCV000332792 | benign | not specified | 2015-07-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000121704 | SCV000520855 | benign | not specified | 2016-10-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000463376 | SCV000559909 | benign | Adams-Oliver syndrome 5 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312816 | SCV000738341 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-02-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000463376 | SCV002553813 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269866 | SCV002553815 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001573999 | SCV003800561 | benign | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000121704 | SCV003928451 | likely benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001573999 | SCV005323724 | benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000121704 | SCV000085902 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
University of Washington Center for Mendelian Genomics, |
RCV001291517 | SCV001480025 | uncertain significance | Hypoplastic left heart syndrome | no assertion criteria provided | research | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001573999 | SCV001800663 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000121704 | SCV001807899 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000121704 | SCV001928040 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000121704 | SCV001959059 | benign | not specified | no assertion criteria provided | clinical testing |